Found: 65
Select item for more details and to access through your institution.
Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 11, p. 1235, doi. 10.3390/life11111235
- By:
- Publication type:
- Article
Editorial: Prognostic factors in non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1174625
- By:
- Publication type:
- Article
The function and clinical implication of circular RNAs in lung cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.862602
- By:
- Publication type:
- Article
PD-1/PD-L1 immunecheckpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.911579
- By:
- Publication type:
- Article
Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.933071
- By:
- Publication type:
- Article
Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.895708
- By:
- Publication type:
- Article
Intratumor microbiota as a novel potential prognostic indicator in mesothelioma.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1129513
- By:
- Publication type:
- Article
Impact of Center Volume on Cardiopulmonary and Mortality Outcomes after Immune-Checkpoint Inhibitors for Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1136, doi. 10.3390/cancers16061136
- By:
- Publication type:
- Article
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2527, doi. 10.3390/cancers14102527
- By:
- Publication type:
- Article
Liquid Biopsies from Pleural Effusions and Plasma from Patients with Malignant Pleural Mesothelioma: A Feasibility Study.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2445, doi. 10.3390/cancers13102445
- By:
- Publication type:
- Article
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178606
- By:
- Publication type:
- Article
In vitro and in vivo characterization of highly purified human mesothelioma derived cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
In vitro and in vivo characterization of highlypurified Human Mesothelioma derived cells.
- Published in:
- BMC Cancer, 2010, v. 10, p. 54, doi. 10.1186/1471-2407-10-54
- By:
- Publication type:
- Article
Malignant Mesothelioma as both a challenge and an opportunity.
- Published in:
- Oncogene, 2004, v. 23, n. 57, p. 9155, doi. 10.1038/sj.onc.1208180
- By:
- Publication type:
- Article
PRMT5 silencing selectively affects MTAP‐deleted mesothelioma: In vitro evidence of a novel promising approach.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 10, p. 5565, doi. 10.1111/jcmm.15213
- By:
- Publication type:
- Article
PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1.
- Published in:
- Journal of Cellular & Molecular Medicine, 2013, v. 17, n. 2, p. 233, doi. 10.1111/jcmm.12000
- By:
- Publication type:
- Article
Epigallocatechin-3-gallate induces mesothelioma cell death via H<sub>2</sub>O<sub>2</sub>−dependent T-type Ca<sup>2+</sup> channel opening.
- Published in:
- Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 11, p. 2667, doi. 10.1111/j.1582-4934.2012.01584.x
- By:
- Publication type:
- Article
MicroRNA Signature of Malignant Mesothelioma with Potential Diagnostic and Prognostic Implications.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2010, v. 42, n. 3, p. 312, doi. 10.1165/rcmb.2009-0060OC
- By:
- Publication type:
- Article
The Presence of Simian-Virus 40 Sequences in Mesothelioma and Mesothelial Cells Is Associated with High Levels of Vascular Endothelial Growth Factor.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2002, v. 26, n. 2, p. 189, doi. 10.1165/ajrcmb.26.2.4673
- By:
- Publication type:
- Article
Neuro–Immune Interactions in Severe COVID-19 Infection.
- Published in:
- Pathogens, 2022, v. 11, n. 11, p. 1256, doi. 10.3390/pathogens11111256
- By:
- Publication type:
- Article
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 9, p. 1964, doi. 10.3390/cells9091964
- By:
- Publication type:
- Article
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 9, p. 1, doi. 10.1038/s41419-020-02940-w
- By:
- Publication type:
- Article
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review.
- Published in:
- La Radiologia Medica, 2023, v. 128, n. 3, p. 316, doi. 10.1007/s11547-023-01602-z
- By:
- Publication type:
- Article
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma.
- Published in:
- International Journal of Biological Markers, 2010, v. 25, n. 3, p. 164, doi. 10.1177/172460081002500307
- By:
- Publication type:
- Article
A Glimpse in the Future of Malignant Mesothelioma Treatment.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.809337
- By:
- Publication type:
- Article
Is There Already a Need of Reckoning on Cancer Immunotherapy?
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.638279
- By:
- Publication type:
- Article
The Impact of 3D Nichoids and Matrix Stiffness on Primary Malignant Mesothelioma Cells.
- Published in:
- Genes, 2024, v. 15, n. 2, p. 199, doi. 10.3390/genes15020199
- By:
- Publication type:
- Article
The Biochemical Role of the Human NEIL1 and NEIL3 DNA Glycosylases on Model DNA Replication Forks.
- Published in:
- Genes, 2019, v. 10, n. 4, p. 315, doi. 10.3390/genes10040315
- By:
- Publication type:
- Article
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state.
- Published in:
- Oncology Reports, 2020, v. 44, n. 6, p. 2406, doi. 10.3892/or.2020.7816
- By:
- Publication type:
- Article
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Thonzonium bromide inhibits progression of malignant pleural mesothelioma through regulation of ERK1/2 and p38 pathways and mitochondrial uncoupling.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03400-7
- By:
- Publication type:
- Article
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e221490, doi. 10.1001/jamanetworkopen.2022.1490
- By:
- Publication type:
- Article
Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies?
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1285031
- By:
- Publication type:
- Article
Primary human mesothelioma cells express class II MHC, ICAM-1 and B7-2 and can present recall antigens to autologous blood lymphocytes.
- Published in:
- International Journal of Cancer, 1998, v. 78, n. 6, p. 740, doi. 10.1002/(SICI)1097-0215(19981209)78:6<740::AID-IJC12>3.0.CO;2-5
- By:
- Publication type:
- Article
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
- Published in:
- Frontiers in Endocrinology, 2019, p. N.PAG, doi. 10.3389/fendo.2019.00089
- By:
- Publication type:
- Article
<i>MSLN</i> Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085935
- By:
- Publication type:
- Article
Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058051
- By:
- Publication type:
- Article
Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036856
- By:
- Publication type:
- Article
Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0014110
- By:
- Publication type:
- Article
Insight into glucocorticoid receptor signalling through interactome model analysis.
- Published in:
- PLoS Computational Biology, 2017, v. 13, n. 11, p. 1, doi. 10.1371/journal.pcbi.1005825
- By:
- Publication type:
- Article
Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma.
- Published in:
- Genes, Chromosomes & Cancer, 2000, v. 29, n. 2, p. 173, doi. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1019>3.0.CO;2-B
- By:
- Publication type:
- Article
Endoplasmic reticulum stress, unfolded protein response and autophagy contribute to resistance to glucocorticoid treatment in human acute lymphoblastic leukaemia cells.
- Published in:
- International Journal of Oncology, 2020, v. 57, n. 3, p. 835, doi. 10.3892/ijo.2020.5089
- By:
- Publication type:
- Article
Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00949
- By:
- Publication type:
- Article
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 4, p. 601
- By:
- Publication type:
- Article
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology.
- Published in:
- Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03744-6
- By:
- Publication type:
- Article
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.684110
- By:
- Publication type:
- Article
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 797, doi. 10.1002/1878-0261.13591
- By:
- Publication type:
- Article
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 797, doi. 10.1002/1878-0261.13591
- By:
- Publication type:
- Article